We are live on
!
Find out more
B
Braidwell Portfolio holdings
AUM
$3B
1-Year Est. Return
46.72%
This Fund
S&P 500
This Quarter
Est. Return
-5.73%
1 Year Est. Return
+46.72%
3 Year Est. Return
+56.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.16B
AUM Growth
+$104M
(+3.4%)
Cap. Flow
-$1.15B
Cap. Flow
% of AUM
-36.22%
Top 10 Holdings %
Top 10 Hldgs %
35.35%
Holding
100
New
14
Increased
28
Reduced
11
Closed
11
Top Buys
| 1 |
BCYC
Bicycle Therapeutics
BCYC
|
+$29.5M |
| 2 |
ETNB
89bio
ETNB
|
+$26.7M |
| 3 |
Immunocore
IMCR
|
+$26M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$25.8M |
| 5 |
Inspire Medical Systems
INSP
|
+$25.3M |
Top Sells
| 1 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
+$47.8M |
| 2 |
Biogen
BIIB
|
+$34.7M |
| 3 |
Align Technology
ALGN
|
+$34.1M |
| 4 |
Aclaris Therapeutics
ACRS
|
+$30.1M |
| 5 |
Glaukos
GKOS
|
+$26M |
Sector Composition
| 1 | Healthcare | 51.8% |
| 2 | Consumer Staples | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Neurocrine Biosciences
NBIX
$17.3B
| $109M | 3.44% |
968,024
+34,662
| +4% | +$3.65M |
|
2
Vaxcyte
PCVX
$8.19B
| $82.6M | 2.61% |
1,619,553
-102,800
| -6% | -$5.07M |
|
3
Xenon Pharmaceuticals
XENE
$6.55B
| $71.9M | 2.27% |
2,103,396
+275,043
| +15% | +$10.3M |
|
4
Boston Scientific
BSX
$64B
| $61.5M | 1.94% |
1,164,850
+447,800
| +62% | +$23.5M |
|
5
Legend Biotech
LEGN
$4.46B
| $59.1M | 1.87% |
879,564
+323,263
| +58% | +$22.5M |
|
6
iRhythm Holdings
IRTC
$3.72B
| $53.6M | 1.69% |
568,157
+89,600
| +19% | +$9.11M |
|
|
7
Glaukos
GKOS
$9.21B
| $52.4M | 1.65% |
695,792
-348,600
| -33% | -$26M |
|
|
8
Immunocore
IMCR
$1.76B
| $47.1M | 1.49% |
906,973
+438,946
| +94% | +$26M |
|
|
DAWN
9
DELISTED
Day One Biopharmaceuticals
DAWN
| $45.6M | 1.44% |
3,715,573
+353,760
| +11% | +$4.61M |
|
10
Natera
NTRA
$39.7B
| $44.8M | 1.42% |
1,012,145
-140,706
| -12% | -$7.18M |
|
11
Keros Therapeutics
KROS
$218M
| $43.3M | 1.37% |
1,357,309
+213,444
| +19% | +$7.97M |
|
|
DCPH
12
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $42.4M | 1.34% |
3,336,221
-310,198
| -9% | -$4.28M |
|
|
FNA
13
DELISTED
Paragon 28, Inc.
FNA
| $42.2M | 1.33% |
3,361,824
+1,225,702
| +57% | +$18.5M |
|
14
Maravai LifeSciences
MRVI
$1.04B
| $39.7M | 1.26% |
3,974,857
+2,170,157
| +120% | +$23.8M |
|
|
15
Thermo Fisher Scientific
TMO
$199B
| $38.3M | 1.21% |
75,749
+48,449
| +177% | +$25.8M |
|
|
16
Align Technology
ALGN
$13B
| $38.2M | 1.21% |
125,213
-98,817
| -44% | -$34.1M |
|
17
BioCryst Pharmaceuticals
BCRX
$2.39B
| $38M | 1.2% |
5,362,980
+2,571,100
| +92% | +$18.5M |
|
|
NVRO
18
DELISTED
NEVRO CORP.
NVRO
| $34.1M | 1.08% |
1,776,368
| – | – |
|
19
OrthoPediatrics
KIDS
$507M
| $33.8M | 1.07% |
1,057,770
+296,562
| +39% | +$11.4M |
|
20
Intuitive Surgical
ISRG
$138B
| $33.6M | 1.06% |
114,920
-8,900
| -7% | -$2.78M |
|
21
Viridian Therapeutics
VRDN
$2.1B
| $26.6M | 0.84% |
1,735,182
+528,882
| +44% | +$10.1M |
|
22
Alector
ALEC
$167M
| $26.4M | 0.83% |
4,074,120
-57,195
| -1% | -$370K |
|
23
Outset Medical
OM
$84M
| $26.1M | 0.83% |
160,028
+62,670
| +64% | +$14.8M |
|
24
Harrow
HROW
$1.6B
| $26M | 0.82% |
1,808,684
+356,146
| +25% | +$6.23M |
|
|
BCYC
25
Bicycle Therapeutics
BCYC
$295M
| $25.9M | 0.82% |
+1,289,872
| New | +$29.5M |
|
Similar funds
NC
VVP
SP
DIG
ECP
PCM
ROTUOC
SM